Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) - Total Assets
Based on the latest financial reports, Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) holds total assets worth $237.63 Million USD as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See shareholders equity of Drugs Made In America Acquisition Corp. for net asset value and shareholders' equity analysis.
Drugs Made In America Acquisition Corp. Ordinary Shares - Total Assets Trend (2024–2024)
This chart illustrates how Drugs Made In America Acquisition Corp. Ordinary Shares's total assets have evolved over time, based on quarterly financial data.
Drugs Made In America Acquisition Corp. Ordinary Shares - Asset Composition Analysis
Current Asset Composition (December 2024)
Drugs Made In America Acquisition Corp. Ordinary Shares's total assets of $237.63 Million consist of 906.1% current assets and -806.1% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 245.3% |
| Accounts Receivable | $0.00 | 0.0% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2024–2024)
This chart illustrates how Drugs Made In America Acquisition Corp. Ordinary Shares's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see DMAA market cap.
Key Asset Composition Facts
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
Drugs Made In America Acquisition Corp. Ordinary Shares Competitors by Total Assets
Key competitors of Drugs Made In America Acquisition Corp. Ordinary Shares based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
M3-Brigade Acquisition V Corp. Units
NASDAQ:MBAVU
|
USA | $308.18 Million |
|
Praetorian Acquisition Corp. Class A Ordinary Shares
NASDAQ:PTOR
|
USA | $57.32K |
|
Helix Acquisition Corp. II Class A Ordinary Shares
NASDAQ:HLXB
|
USA | $197.39 Million |
|
Marblegate Acquisition Corp
NASDAQ:GATE
|
USA | $4.17 Million |
|
Bluerock Acquisition Corp. Class A Ordinary Shares
NASDAQ:BLRK
|
USA | $571.66K |
|
Mountain & I Acquisition Co Corp
NASDAQ:MCAA
|
USA | $96.04 Million |
|
Dune Acquisition Corporation II Class A Ordinary Shares
NASDAQ:IPOD
|
USA | $148.30 Million |
|
Tavia Acquisition Corp. Unit
NASDAQ:TAVIU
|
USA | $120.09 Million |
Drugs Made In America Acquisition Corp. Ordinary Shares - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.00 | 0.37 |
| Quick Ratio | 0.06 | 0.00 | 0.37 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-428.42K | $-588.90K | $-132.89 |
Drugs Made In America Acquisition Corp. Ordinary Shares - Advanced Valuation Insights
This section examines the relationship between Drugs Made In America Acquisition Corp. Ordinary Shares's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 637094.72 |
| Asset Growth Rate (YoY) | 0.0% |
| Total Assets | $550.82 |
| Market Capitalization | $350.92 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Drugs Made In America Acquisition Corp. Ordinary Shares's assets at a significant premium (637094.72x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Drugs Made In America Acquisition Corp. Ordinary Shares's assets decreased by 0.0% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Drugs Made In America Acquisition Corp. Ordinary Shares (2024–2024)
The table below shows the annual total assets of Drugs Made In America Acquisition Corp. Ordinary Shares from 2024 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $550.82 | -- |
About Drugs Made In America Acquisition Corp. Ordinary Shares
Drugs Made In America Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. Drugs Made In America Acquisition Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.